Nzyme, a Spanish non-public fairness fund backed by Kibo Ventures, has introduced its ultimate closing at €160 million to put money into Spanish corporations working in extremely fragmented B2B sectors, with a concentrate on conventional companies which have robust transformation potential via the adoption of expertise and sector consolidation.
The fund has attracted help from a various base of buyers, together with the dedication of CDTI via its SICC Innvierte, in addition to Spanish enterprise households, profitable entrepreneurs who determine with the fund’s technique, banks, and worldwide household places of work with pursuits in Spain.
Vicente Vázquez, Managing Director at Nzyme, stated: “The profitable closing of this fund, in a difficult surroundings, confirms buyers’ confidence within the Nzyme staff, our technique, and the potential of Spanish SMEs to rework and develop. We’re satisfied that by combining enterprise consolidation with technological innovation, we are able to create robust leaders in conventional and fragmented sectors.
“We stay dedicated to producing sustainable worth and contributing to the nation’s financial growth via strategic investments and an in depth, hands-on strategy with the businesses.”
Nzyme is the newest enterprise capital fund launched by Kibo Ventures, with the mission to catalyse the transformation of the businesses and industries wherein it invests. Kibo Ventures is a VC agency was based in 2012 to empower revolutionary European tech entrepreneurs to deal with important challenges and obtain development by constructing international corporations.
Nzyme prioritises funding in service and software program corporations inside fragmented industries, characterised by their potential to generate worth via sustainability and expertise.
Moreover, Nzyme’s administration staff is made up of execs with expertise in non-public fairness, expertise, and enterprise transformation, together with Fernando Díaz Solís, Vicente Vázquez Bouza, José Manuel Gasalla, Juan López Santamaría, and Pablo Campos, supported by the Kibo Ventures community.
Moreover, the fund has Oliver Wyman as a strategic advisor, which permits Nzyme to entry superior sector analyses, channel proprietary alternatives, and facilitate the internationalisation of the businesses in its portfolio.
The fund has already made its first investments, together with a notable entry into healthcare distribution, built-in into Kuma Group, in addition to a number of investments in skilled companies corporations. These transactions are a part of Nzyme’s strategic undertaking to construct trade leaders via consolidation and technological innovation in fragmented sectors.
As well as, the fund has superior plans to combine different corporations that can additional strengthen the expansion of its portfolio.
In April 2025, Nzyme accomplished the divestment of Kuma’s dental division, lower than two years after its acquisition, reaffirming its potential to create worth via lively transformation and development methods.
The fund explains that they make investments with “a prudent and hands-on strategy, specializing in well-managed corporations with stable buildings, supporting them of their enlargement processes“. The fund prioritizes shut collaboration with Founders and administration groups to facilitate institutionalisation, generational shift, and internationalisation.
The target is to help corporations which have confirmed their value of their native markets, a lot of them positioned outdoors main city facilities, in scaling up, professionalising, and successfully adopting expertise. On this course of, the fund gives key help in one of the crucial complicated challenges of enterprise development: transitioning from buildings of 20–40 workers to organisations of over 150 folks, with scalable processes, built-in expertise, and worldwide ambition.
Nzyme targets corporations with EBITDA beginning at roughly €1 million or round 20 workers as a place to begin to construct sector platforms. The fund anticipates a portfolio of 8 to 10 platforms, making particular person investments of between €15 and €20 million via the acquisition and integration of a number of corporations.
The technique combines inorganic development with the adoption of superior applied sciences – resembling AI, massive information, machine studying, IoT, edge computing, and cloud – to drive operational effectivity, scalability, and aggressive differentiation.
With an lively strategy, the fund applies the basic non-public fairness levers – administration succession, institutionalisation, and worldwide enlargement – integrating expertise as a driver of sustainable development and worth creation.
Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our publication, and be a part of our rising group at nextbusiness24.com
